111 related articles for article (PubMed ID: 1770692)
21. [Continuous treatment of asthma in children with theophylline retard].
de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
[TBL] [Abstract][Full Text] [Related]
22. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
[No Abstract] [Full Text] [Related]
23. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
Miyazaki Y; Yakou S; Takayama K
J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
Kotake T; Mihara M; Shibakawa M; Asamoto
Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
26. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
27. Day-night differences in steady-state theophylline pharmacokinetics in asthmatic children.
Scott PH; Kramer WG; Smolensky MH; Harrist RB; Hiatt PW; Baenziger JC; Klank BJ; Eigen H
Chronobiol Int; 1989; 6(2):163-71. PubMed ID: 2743469
[TBL] [Abstract][Full Text] [Related]
28. [A case of theophylline-induced rhabdomyolysis following therapy of bronchial asthma].
Aoshima M; Kameyama S; Murai Y; Yamazaki M; Kamiya T; Miyazaki T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1064-9. PubMed ID: 1753524
[TBL] [Abstract][Full Text] [Related]
29. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
30. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
[No Abstract] [Full Text] [Related]
31. [Asthma patients requiring unusually high doses of theophylline].
Matsumura Y; Shiga M; Otsuka H; Tomoe Y; Sugiyama H; Nakamura T
Arerugi; 1989 Mar; 38(3):272-6. PubMed ID: 2751434
[TBL] [Abstract][Full Text] [Related]
32. Development of severe Stevens-Johnson syndrome after administration of slow-release theophylline.
Brook U; Singer L; Fried D
Pediatr Dermatol; 1989 Jun; 6(2):126-9. PubMed ID: 2748473
[TBL] [Abstract][Full Text] [Related]
33. [Aggressive behavior as a side effect of ethylenediamine (but not of theophylline)].
Niggemann B
Monatsschr Kinderheilkd; 1985 Jul; 133(7):487. PubMed ID: 4047061
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
[TBL] [Abstract][Full Text] [Related]
35. Intravenous theophylline?
Szymaniak G; Anderer TJ
Hosp Pharm; 1983 Dec; 18(12):665-6, 670. PubMed ID: 10264360
[TBL] [Abstract][Full Text] [Related]
36. Ribavirin influence on theophylline plasma levels in adult and children.
Fraschini F; Scaglione F; Maierna G; Cogo R; Furcolo F; Gattei R; Borghi C; Palazzini E
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):30-2. PubMed ID: 3042639
[TBL] [Abstract][Full Text] [Related]
37. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects.
Crescioli S; Spinazzi A; Plebani M; Pozzani M; Mapp CE; Boschetto P; Fabbri LM
Ann Allergy; 1991 Mar; 66(3):245-51. PubMed ID: 2006773
[TBL] [Abstract][Full Text] [Related]
38. [Anxiety crisis (panic attack) secondary to the administration of theophylline in an oral sustained-release preparation].
Gea J; de Pablo J; Martí J; Picado C; Pujol A; Agustí-Vidal A
Rev Clin Esp; 1988 Oct; 183(5):280. PubMed ID: 3212257
[No Abstract] [Full Text] [Related]
39. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
[TBL] [Abstract][Full Text] [Related]
40. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
Mosbech H; Paulsen H; Søborg M
Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
